Evaluation of the Effectiveness of Solution-Focused Brief group Therapy on reducing Anxiety and Depression.

Investigating the Effectiveness of Solution-Focused Brief Group Therapy (SFBT) on reducing Anxiety and Depression in Patients admitted to the Neuropsychiatric Department Compared to the Control Group.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220706055395N1

Enrollment

Registered

2022-07-19

Start date

2022-08-11

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Depression. Condition 2: Anxiety. Major depressive disorder, single episode Anxiety disorder due to known Physiological condition

Interventions

Intervention 1: In the Experimental Group, the Intervention with Short-term Solution-oriented Treatment is carried out for six 45-minute Sessions (two Sessions per Week) in the Psychiatric Department

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with Anxiety and Depression Disorders admitted to the Psychiatric Ward Patients 18 to 60 years old

Exclusion criteria

Exclusion criteria: Psychotic or Mania Patients Patients with Personality Disorders Substance Abuse Patients Mentally Retarded Patients

Design outcomes

Primary

Measure	Time frame
The Percentage of People who Score higher than 21 in the Depression Subscale of the DASS-21 Questionnaire. Timepoint: Depression in the intervention Group is measured at the beginning of Hospitalization (before the intervention) and after the intervention (after three weeks). In the Control group, it is measured from the beginning of Hospitalization and after three Weeks. Method of measurement: Depression is measured by the Depression Subscale of the Depression- Anxiety- Stress Scale(DASS-21) Questionnaire.;The Percentage of People who Score higher than 15 in the Anxiety-Stress Subscale of the DASS-21 Questionnaire. Timepoint: Anxiety in the intervention Group is measured at the beginning of Hospitalization (before the intervention) and after the intervention (after three weeks). In the Control group, it is measured from the beginning of Hospitalization and after three Weeks. Method of measurement: Anxiety is measured by the Anxiety Subscale of the DASS-21 qQuestionnaire.	—

Measure

Time frame

The Percentage of People who Score higher than 21 in the Depression Subscale of the DASS-21 Questionnaire. Timepoint: Depression in the intervention Group is measured at the beginning of Hospitalization (before the intervention) and after the intervention (after three weeks). In the Control group, it is measured from the beginning of Hospitalization and after three Weeks. Method of measurement: Depression is measured by the Depression Subscale of the Depression- Anxiety- Stress Scale(DASS-21) Questionnaire.;The Percentage of People who Score higher than 15 in the Anxiety-Stress Subscale of the DASS-21 Questionnaire. Timepoint: Anxiety in the intervention Group is measured at the beginning of Hospitalization (before the intervention) and after the intervention (after three weeks). In the Control group, it is measured from the beginning of Hospitalization and after three Weeks. Method of measurement: Anxiety is measured by the Anxiety Subscale of the DASS-21 qQuestionnaire.

—

Secondary

Measure	Time frame
. Timepoint: . Method of measurement: .	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Abdollahi

Semnan University of Medical Sciences

abdollahi.mahsa631@yahoo.com+98 23 3142 2391

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026